Cord Bank America’s (CBAI.OB) share price rose 17.65% during Wednesday’s trading hours. Because an above average 1,300,000 shares were exchanged, the stock price reacted favorably. This upward momentum could continue during the upcoming trading sessions as investors have taken a keen eye on Cord Bank America and their wholly owned subsidiaries.
Recently, Cord Bank announced that the company has finalized a partnership with Progenitor Labs. Under the terms of this agreement, Progenitor Labs will handle the processing and storage of collected cord blood. Subsequently, this agreement will allow Cord Bank’s customers the unique opportunity to access the latest cell therapy advances in medicine.
Cord Bank America’s wholly owned subsidiary ‘Cord Partners’ also allows customers to access the latest stem cell therapy advances. Specifically, this wholly owned subsidiary is focused on providing individual families with the distinct opportunity of investing in their future health through the promise of regenerative medicine. Because Cord Partner banks children’s blood stem cells, families can invest in their child’s future and potentially save a life.
Let us hear your thoughts: Cord Blood America Inc. Message Board